Latest Whitepapers

This app note presents a novel protocol for generating larger quantities of invariant NK (iNK) cells from pluripotent stem cells (PSCs) using cytokine cocktails.

This article explores how cell-to-cell communication can be targeted for novel treatment methods.

Liquid biopsies are a minimally invasive alternative that can detect the presence of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) as tumor biomarkers.

Harnessing the cytotoxic potential of T cells through immunotherapy has revolutionized cancer treatment, but the effectiveness of T-cell therapeutics is still limited in solid tumors.

This whitepaper demonstrates how common methylation detection methods can be combined with Droplet Digital PCR (ddPCR) to enhance the cfDNA analysis for clinical and research applications.

This whitepaper explores groundbreaking organ-on-a-chip technology and 3D tissue modeling that is closing the translational gap in cancer drug discovery.

This whitepaper explores the advantages of a novel cell sorting and dispensing platform – which combines microfluidics, flow cytometry and liquid dispensing – that can help researchers get to their optimal clones more efficiently.

This article explores how we can find new ways to stop tumor growth and prevent drug resistance by targeting the language of cancer cell communication.

When assessing PARP enzymatic activity for drug development, each component must be carefully optimized to ensure sensitivity, robustness and reproducibility. This whitepaper explores methods and reagents available to evaluate drug specificity and effectiveness.

This whitepaper explores the tools available to characterize antibody binding to Fc receptors, including quantitative assays to support optimization of therapeutic products.